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 Supplementary tables. 
 
Table A1.  SAGE response rates and missing data.  
 
 




Target sample (n) 14,280 5,493 7,511 4,414 4,785 4,937 
Complete/partial interview 
(n) 
13,175 4,305 6,560 2,313 3,938 3,837 
Response rate (%) 92.3 78.4 87.3 52.4 82.3 77.7 
Blood pressure 
measurements recorded (n) 




95 99 99 92 95 97 
Missing education data for 
interviews with blood 
pressure measurement (n) 
0 27 0 66 2 579 
Missing BMI data for 
interviews with blood 
pressure measurement (n) 
179 114 177 142 409 238 
Missing smoking data for 
interviews with blood 
pressure measurement (n) 
50 16 2 66 23 111 
Missing alcohol data for 
interviews with blood 
pressure measurement (n) 
61 22 1 66 19 118 
Missing physical activity 
data for interviews with 
blood pressure 
measurement (n) 
7 5 0 66 15 83 
Missing income data for 
interviews with blood 
pressure measurement (n) 
57 5 38 1 5 18 
Missing insurance data for 
interviews with blood 
pressure measurement (n) 
80 3 0 13 16 40 
 Table A2 Prevalence of effective treatment and adjusted model for effective treatment in hypertensive participants under treatment (Odds Ratios with 95% 
Confidence Intervals). 
 
  Overall China Ghana India Mexico Russian Federation South Africa 
  (n=6687) (n=2470) (n=395) (n=497) (n=438) (n=1365) (n=715) 
Prevalence  of effective treatment (%) 
Total 26.3 (25.3-27.3) 24.0 (22.3-25.7) 23.7 (19.6-27.8) 55.2 (50.9-59.5) 30.3 (26.2-34.4) 17.4 (15.5-19.3) 23.5 (20.8-26.2) 
Male 28.3 (26.6-30.0) 27.6 (24.9-30.3) 26.2 (19.8-32.6) 55.4 (49.0-61.8) 21.1 (14.9-27.3) 17.5 (14.0-21.0) 20.5 (16.2-24.8) 
Female 25.1 (23.8-26.4) 21.4 (19.3-23.5) 21.8 (16.5-27.1) 55.0 (49.3-60.7) 35.3 (30.0-40.6) 17.3 (15.0-19.6) 25.2 (21.7-28.7) 
Odds Ratios 
Age (years) 
[50-54) 1 1 1 1 1 1 1 
[55-59) 1.22 (1.00-1.50) 1.02 (0.71-1.47) 1.58 (0.62-4.05) 1.49 (0.81-2.73) 4.04 (1.26-12.9) 0.95 (0.55-1.63) 0.76 (0.40-1.42) 
[60-64) 1.11 (0.89-1.38) 0.86 (0.59-1.25) 0.68 (0.21-2.14) 1.50 (0.76-2.97) 1.28 (0.39-4.22) 1.81 (1.03-3.16) 0.37 (0.18-0.76) 
[65-69) 1.16 (0.94-1.44) 0.91 (0.63-1.32) 1.23 (0.46-3.26) 1.68 (0.84-3.34) 1.07 (0.32-3.54) 1.49 (0.85-2.64) 1.35 (0.75-2.43) 
[70+ 0.93 (0.76-1.14) 0.81 (0.57-1.14) 1.04 (0.43-2.53) 1.78 (0.95-3.31) 1.28 (0.42-3.91) 0.82 (0.47-1.41) 0.65 (0.36-1.16) 
Sex 
Males 1 1 1 1 1 1 1 
Females 0.92 (0.81-1.04) 0.76 (0.61-0.94) 1.26 (0.72-2.21) 0.76 (0.47-1.23) 1.43 (0.83-2.44) 1.18 (0.83-1.68) 1.37 (0.89-2.12) 
BMI  
Normal 1 1 1 1 1 1 1 
Underweight 1.97 (1.46-2.65) 0.96 (0.49-1.87) 0.78 (0.25-2.40) 1.97 (1.10-3.54) 13.2 (0.23-743.5) <0.001 (<0.001- >999) 3.54 (1.30-9.65) 
Overweight 0.76 (0.66-0.87) 0.70 (0.57-0.86) 0.38 (0.20-0.72) 1.33 (0.82-2.15) 1.18 (0.61-2.26) 0.59 (0.39-0.90) 0.94 (0.49-1.80) 
Obese 0.45 (0.38-0.53) 0.58 (0.40-0.85) 0.29 (0.13-0.64) 1.90 (0.80-4.52) 0.82 (0.41-1.66) 0.28 (0.18-0.44) 1.05 (0.58-1.91) 
Health insurance 
Insured 1 1 1 1 1 1 1 
Uninsured 2.34 (2.04-2.69) 1.30 (0.97-1.74) 0.91 (0.54-1.53) 0.68 (0.35-1.30) 0.51 (0.27-0.96) 4.43 (0.33-59.6) 0.99 (0.62-1.56) 
Location 
Urban 1 1 1 1 1 1 1 
Rural 0.59 (0.51-0.67) 0.30 (0.22-0.39) 0.58 (0.30-1.13) 0.72 (0.47-1.12) 1.36 (0.79-2.33) 0.48 (0.32-0.73) 0.82 (0.52-1.32) 
Education  
Primary 1 1 1 1 1 1 1 












 Secondary/Higher 0.98 (0.85-1.14) 1.23 (0.98-1.55) 0.56 (0.26-1.16) 0.92 (0.53-1.59) 0.94 (0.49-1.83) 0.68 (0.38-1.20) 1.77 (1.11-2.82) 
Wealth quintile 
Poorest 1 1 1 1 1 1 1 
Q2 1.08 (0.85-1.36) 1.04 (0.70-1.53) 0.47 (0.10-2.10) 2.07 (0.75-5.71) 0.85 (0.38-1.91) 0.85 (0.47-1.54) 3.37 (1.60-7.08) 
Q3 1.13 (0.90-1.42) 1.04 (0.71-1.52) 0.58 (0.16-2.05) 1.04 (0.40-2.71) 1.69 (0.76-3.73) 0.77 (0.43-1.39) 1.92 (0.90-4.08) 
Q4 1.51 (1.21-1.87) 1.06 (0.73-1.54) 0.65 (0.19-2.16) 1.48 (0.60-3.63) 1.73 (0.79-3.76) 1.41 (1.78-2.53) 4.01 (1.90-8.43) 
Richest 1.55 (1.25-1.92) 0.84 (0.58-1.24) 1.41 (0.43-4.58) 1.32 (0.53-3.25) 1.22 (0.57-2.60) 1.37 (0.76-2.48) 3.04 (1.45-6.35) 
Alcohol 
consumption 
Life time abstainers 1 1 1 1 1 1 1 
Non heavy drinker 1.00 (0.84-1.20) 0.85 (0.62-1.18) 2.98 (1.55-5.70) 0.58 (0.22-1.55) 0.72 (0.26-2.00) 1.55 (1.08-2.24) 0.28 (0.10-0.81) 
Infrequent heavy 
drinkers 
1.20 (0.76-1.89) 0.66 (0.22-1.96) - - 0.14 (0.03-0.60) 3.87 (1.55-9.68) 1.34 (0.28-6.33) 
Frequent heavy 
drinkers 
0.69 (0.36-1.32) 1.23 (0.61-2.47) 
<0.001 (<0.001 - 
>999) 
<0.001 (<0.001 - 
>999) 
- 0.07 (<0.001-53.4) 
<0.001 (<0.001 - 
>999) 
Physical activity 
High 1 1 1 1 1 1 1 
Moderate 0.99 (0.85-1.14) 1.10 (0.87-1.39) 1.16 (0.52-2.56) 0.76 (0.46-1.25) 1.28 (0.69-2.39) 0.81 (0.53-1.23) 2.04 (1.01-4.12) 













 Table A3.  Age-adjusted prevalence of hypertension  in SAGE participants over the age of 50 years 
[95%CI] and 
selected national development indicators.  
 SAGE participants National development indicators 
























































































32.8 15,630 72.9 100 0.719 
*Sources: World Urbanization Prospects: The 2009 Revision Population Database 
http://esa.un.org/unpd/wpp/index.htm; 
World Development Report 2010 http://econ.worldbank.org/wdr/   
§
 This index combines life expectancy, years of schooling and per capita income (Human 
Development Report 2010). 
 
 
 
  
 
 
